ISSCR Innovation Showcase: Differentiating Immune Cells from Human Pluripotent Stem Cells in Feeder- and Serum-Free Cultures

In this Innovation Showcase talk from ISSCR 2020 Virtual, Dr. Nooshin Tabatabaei-Zavareh demonstrates how to differentiate immune cells from human pluripotent stem cells (hPSCs) in feeder- and serum-free cultures.

hPSCs may provide an unlimited source of immune cells for disease modeling, gene editing, and cell therapy development applications. Differentiation of hPSCs into immune cells is challenging and often involves the use of serum and feeder cells, which can be difficult to standardize. Dr. Tabatabaei-Zavareh reviews the development of multi-step feeder- and serum-free culture systems for differentiating hPSCs into T cells, NK cells, or monocytes, which are similar to their counterparts in peripheral blood. Her results show that hPSCs can be differentiated under feeder- and serum-free conditions into immune cells for basic and translational research.

As a supporter of, and participant in, ISSCR’s 2021 Annual Meeting, we share with you our Innovation Showcase presentation at #ISSCR2021.
This presentation does not represent an endorsement from or support of the ISSCR.
Publish Date: August 17, 2020 Views: 0

Contact STEMCELL Technologies

Our Customer Service, Sales, and Product and Scientific Support departments in North America are available between 6 am and 5 pm Pacific Time (9 am and 8 pm Eastern Time). One of our representatives will be happy to help you by telephone or email. Please complete the form to contact us by email. A representative will get back to you shortly.
  •  

StemCell Technologies Inc. and affiliates ("STEMCELL Technologies") does not share your email address with third parties. StemCell Technologies Inc. will use your email address to confirm your identity and send you newsletters, transaction-related emails, promotional and customer service emails in accordance with our privacy policy. You can change your email preferences at any time.